Officials from multiple federal health agencies took part in a conference this week to discuss the state of marijuana science and policy considerations for researchers navigating cannabis studies under ongoing prohibition—with a focus on the potential of cannabinoids and terpenes to treat pain. The event, organized by the National Center for Complementary and Integrative Health … Continue reading Federal Health Officials Discuss Marijuana Research And Rescheduling Implications, But DEA Cancels Scheduled Appearance